Search

Search Results

• Predictive radiomics signature for treatment response to nivolumab in patients with advanced renal cell carcinoma

  Eoghan R. Malone, Hao-Wen Sim, Audrius Stundzia, Sacha Pierre, Ur Metser, Martin O'Malley, Adrian G. Sacher, Srikala S. Sridhar, Aaron R. Hansen

  2021-08-20

• Treatment options in advanced renal cell carcinoma after first-line treatment with vascular endothelial growth factor receptor tyrosine kinase inhibitors

  Naveen S. Basappa

  S242-4

  2016-12-15

• Response of renal cell carcinoma to ibrutinib, a bruton tyrosine kinase inhibitor, in a patient treated for chronic lymphocytic leukemia

  Gregory W. Hosier, Naji J. Touma

  E237-9

  2017-05-09